Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
40 studies found for:    (HIV infections) [CONDITION] AND vaccine [TREATMENT] | Open Studies
Show Display Options
Rank Status Study
21 Recruiting Safety, Tolerability and Immunogenicity Study of Different Vaccine Regimens of Trivalent Ad26.Mos.HIV or Tetravalent Ad26.Mos4.HIV Along With Clade C Glycoprotein (gp)140 in Healthy Human Immunodeficiency Virus (HIV)-Uninfected Adults
Condition: Healthy
Interventions: Biological: Ad26.Mos.HIV;   Biological: Ad26.Mos4.HIV;   Biological: Clade C gp140;   Drug: Placebo
22 Recruiting Study of Immune Responses Induced by a HIV Vaccine
Condition: HIV Infections
Interventions: Biological: AIDSVAX B/E;   Biological: AIDSVAX B/E Placebo
23 Recruiting Safety and Immunogenicity of HIV DNA-C CN54ENV and Recombinant HIV CN54gp140 Vaccines in Healthy Volunteers
Condition: HIV
Interventions: Biological: DNA-C CN54ENV;   Biological: CN54gp140;   Device: Trigrid Delivery System - Intramuscular;   Device: Trigrid Delivery System - Intradermal
24 Recruiting Safety and Immunogenicity of Anti-Pneumococcal Vaccines in HIV-Infected Pregnant Women
Conditions: PNC Vaccine;   HIV-infected Pregnant Women
Interventions: Biological: PPV-23;   Biological: PCV-10;   Other: NaCl
25 Recruiting DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a 2nd Year of Life Booster in HIV-Exposed Infected and Uninfected
Conditions: Diphtheria;   Tetanus;   Pertussis;   Hepatitis B;   Polio;   Human Immunodeficiency Virus Infection
Intervention: Biological: Hexaxim®: DTaP-IPV-HB-PRP-T Combined Vaccine
26 Recruiting Mechanisms of Impaired HIV-associated B Cell and Pneumococcal Vaccine Responses
Conditions: HIV;   Pneumococcal Infections;   Pneumococcal Vaccines
Interventions: Biological: PCV-13;   Biological: PPSV-23
27 Recruiting Safety, Tolerability and Immunogenicity Study of 3 Prime-boost Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo in Healthy Adults, Children and Human Immunodeficiency Virus Positive (HIV+) Adults
Condition: Hemorrhagic Fever, Ebola
Interventions: Biological: Ad26.ZEBOV;   Biological: MVA-BN-Filo;   Biological: Placebo
28 Not yet recruiting REMUNE + AMPLIVAX IR103 HIV/AIDS Phase III Safety & Efficacy Study
Condition: HIV
Intervention: Biological: IR103
29 Recruiting Research In Viral Eradication of HIV Reservoirs
Condition: HIV
Interventions: Drug: Combination Antiretroviral Therapy (cART);   Drug: Raltegravir;   Drug: Vorinostat;   Biological: ChAdV63.HIVconsv (ChAd);   Biological: MVA.HIVconsv (MVA)
30 Recruiting Pilot Trial of the Effect of Vorinostat and AGS-004 on Persistent HIV-1 Infection
Condition: HIV-1 Infection
Interventions: Drug: Vorinostat;   Biological: AGS-004
31 Recruiting Imiquimod and Influenza Vaccine for Immunocompromised Patients
Condition: Influenza Vaccine
Interventions: Biological: Intanza;   Biological: Mutagrip;   Drug: Aldara
32 Recruiting Multi Interventional Study Exploring HIV-1 Residual Replication: a Step Towards HIV-1 Eradication and Sterilizing Cure
Conditions: Chronic Infection;   HIV
Interventions: Drug: Maraviroc;   Drug: Dolutegravir;   Biological: Dendritic Cell Vaccination;   Drug: Auranofin;   Drug: Sirtuin Histone deacetylase inhibitor
33 Recruiting Perturbing of HIV Reservoir With Immune Stimulation
Conditions: AIDS;   HIV
Interventions: Biological: Fluarix;   Biological: Pneumovax;   Other: Placebo
34 Recruiting A Pilot Study Comparing the Immunogenicity of Fendrix vs. Double-dose Engerix B in HIV-infected Non-responders to Standard Hepatitis B Vaccination Courses
Conditions: HIV;   Communicable Diseases;   Hepatitis B;   HBV;   Infectious Diseases
Interventions: Drug: Engerix B;   Drug: Fendrix
35 Recruiting A Phase 1, Randomized, Blinded, Dose-escalation Study of rAAV1-PG9DP Recombinant AAV Vector Coding for PG9 Antibody in Healthy Male Adults.
Condition: HIV Infections
Intervention: Biological: rAAV1-PG9DP
36 Recruiting Improving Identification of Social Harm Among Substance Abusers in HIV Trials
Conditions: Social Harms in Substance Users in HIV Trials;   Audio Computer Assisted Self-administered Questionnaire
Intervention:
37 Recruiting CD34+ Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation for Non-Malignant Disease
Conditions: Bone Marrow Failure Syndrome;   Severe Aplastic Anemia;   Severe Congenital Neutropenia;   Amegakaryocytic Thrombocytopenia;   Diamond-Blackfan Anemia;   Schwachman Diamond Syndrome;   Primary Immunodeficiency Syndromes;   Acquired Immunodeficiency Syndromes;   Histiocytic Syndrome;   Familial Hemophagocytic Lymphocytosis;   Lymphohistiocytosis;   Macrophage Activation Syndrome;   Langerhans Cell Histiocytosis (LCH);   Hemoglobinopathies;   Sickle Cell Disease;   Sickle Cell-beta-thalassemia
Intervention: Biological: CD34 Stem Cell Selection Therapy
38 Recruiting Causes of Rotavirus Vaccine Failure in Zambian Children
Condition: Diarrhoea
Intervention:
39 Recruiting Integrated Stepped Care for Unhealthy Alcohol Use in HIV
Conditions: Liver Diseases, Alcoholic;   Alcoholism;   HIV;   Hepatitis C
Interventions: Other: Integrated Stepped Care (ISC);   Other: Treatment as Usual
40 Not yet recruiting Improving South African Government Workers' Capacities to Deliver HIV Interventions
Conditions: HIV;   Partner Violence;   Malnutrition;   Alcohol Use/Abuse;   Depression
Interventions: Behavioral: Accountable Condition;   Behavioral: Control Condition

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page   
Study has passed its completion date and status has not been verified in more than two years.